Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) generation in bacteria refers to the metabolic and environmental production of reactive molecules such as superoxide anion, hydrogen peroxide, hydroxyl radical, and singlet oxygen during aerobic respiration, exposure to stress, antibiotics, or immune attack. These species damage bacterial DNA, proteins, and membranes, triggering antibacterial effects. Bacteria counteract ROS with multiple antioxidant systems (e.g., catalase, superoxide dismutase, regulatory genes like OxyR, SoxRS), and their ability to tolerate or neutralize ROS is key to their survival during infection or antibiotic treatment. Although the process is exploited in drug development (for example, redox-active antimicrobials), "ROS generation in bacteria" itself is not a single target but a group of processes and contributing molecular components.
Drug-induced ROS causes bacterial cell damage via oxidative stress to DNA, lipids, and proteins. Some antibiotics and nanozymes target this process to kill bacteria by overwhelming their antioxidant defences
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation in bacteria.